These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21356126)

  • 1. Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer.
    Roeder F; Zwicker F; Saleh-Ebrahimi L; Timke C; Thieke C; Bischof M; Debus J; Huber PE
    Radiat Oncol; 2011 Mar; 6():22. PubMed ID: 21356126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinoma.
    Puebla F; Lopez Guerra JL; Garcia Ramirez JM; Matute R; Marrone I; Miguez C; Sevillano D; Sanchez-Reyes A; Rivin Del Campo E; Praena-Fernandez JM; Azinovic I
    Clin Transl Oncol; 2015 Nov; 17(11):925-31. PubMed ID: 26108408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
    Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysis.
    Saleh-Ebrahimi L; Zwicker F; Muenter MW; Bischof M; Lindel K; Debus J; Huber PE; Roeder F
    Radiat Oncol; 2013 Jan; 8():20. PubMed ID: 23347410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
    Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
    Qiu S; Lin S; Tham IW; Pan J; Lu J; Lu JJ
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):676-83. PubMed ID: 22024207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.
    Agas RAF; Yu KKL; Sogono PG; Co LBA; Jacinto JCKM; Bacorro WR; Mejia MBA
    J Glob Oncol; 2019 Feb; 5():1-14. PubMed ID: 30735433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after reirradiation for recurrent nasopharyngeal carcinoma: North American experience.
    Karam I; Huang SH; McNiven A; Su J; Xu W; Waldron J; Bayley AJ; Kim J; Cho J; Ringash J; Hope A; Chen E; Chan B; Goldstein D; O'Sullivan B; Giuliani ME
    Head Neck; 2016 Apr; 38 Suppl 1():E1102-9. PubMed ID: 26451876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
    Hwang JM; Fu KK; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
    De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
    J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
    Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.
    McAvoy S; Ciura K; Wei C; Rineer J; Liao Z; Chang JY; Palmer MB; Cox JD; Komaki R; Gomez DR
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):819-27. PubMed ID: 25220718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma.
    Dionisi F; Croci S; Giacomelli I; Cianchetti M; Caldara A; Bertolin M; Vanoni V; Pertile R; Widesott L; Farace P; Schwarz M; Amichetti M
    Acta Oncol; 2019 Sep; 58(9):1238-1245. PubMed ID: 31155998
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Han L; Lin SJ; Pan JJ; Chen CB; Zhang Y; Zhang XC; Liao XY; Chen QS
    Chin J Cancer; 2010 Feb; 29(2):145-50. PubMed ID: 20109341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reirradiation with intensity-modulated radiotherapy in recurrent head and neck cancer.
    Zwicker F; Roeder F; Hauswald H; Thieke C; Timke C; Schlegel W; Debus J; Münter MW; Huber PE
    Head Neck; 2011 Dec; 33(12):1695-702. PubMed ID: 21284054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.